PRKCA and multiple sclerosis: association in two independent populations.

Janna Saarela, Suvi P. Kallio, Daniel Chen, Alexandre Montpetit, Anne Jokiaho, Eva Choi, Rosanna Asselta, Denis Bronnikov, Matthew R. Lincoln, A. Dessa Sadovnick, Pentti J. Tienari, Keijo Koivisto, Aarno Palotie, George C. Ebers, Thomas J. Hudson, Leena Peltonen

Research output: Contribution to journalArticle

Abstract

Multiple sclerosis (MS) is a chronic disease of the central nervous system responsible for a large portion of neurological disabilities in young adults. Similar to what occurs in numerous complex diseases, both unknown environmental factors and genetic predisposition are required to generate MS. We ascertained a set of 63 Finnish MS families, originating from a high-risk region of the country, to identify a susceptibility gene within the previously established 3.4-Mb region on 17q24. Initial single nucleotide polymorphism (SNP)-based association implicated PRKCA (protein kinase C alpha) gene, and this association was replicated in an independent set of 148 Finnish MS families (p = 0.0004; remaining significant after correction for multiple testing). Further, a dense set of 211 SNPs evenly covering the PRKCA gene and the flanking regions was selected from the dbSNP database and analyzed in two large, independent MS cohorts: in 211 Finnish and 554 Canadian MS families. A multipoint SNP analysis indicated linkage to PRKCA and its telomeric flanking region in both populations, and SNP haplotype and genotype combination analyses revealed an allelic variant of PRKCA, which covers the region between introns 3 and 8, to be over-represented in Finnish MS cases (odds ratio = 1.34, 95% confidence interval 1.07-1.68). A second allelic variant, covering the same region of the PRKCA gene, showed somewhat stronger evidence for association in the Canadian families (odds ratio = 1.64, 95% confidence interval 1.39-1.94). Initial functional relevance for disease predisposition was suggested by the expression analysis: The transcript levels of PRKCA showed correlation with the copy number of the Finnish and Canadian "risk" haplotypes in CD4-negative mononuclear cells of five Finnish multiplex families and in lymphoblast cell lines of 11 Centre d'Etude du Polymorphisme Humain (CEPH) individuals of European origin.

Original languageEnglish
JournalPLoS Genetics
Volume2
Issue number3
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Protein Kinase C-alpha
sclerosis
protein kinase C
Multiple Sclerosis
protein
Single Nucleotide Polymorphism
Population
polymorphism
single nucleotide polymorphism
gene
confidence interval
odds ratio
Haplotypes
Genes
haplotypes
genes
Odds Ratio
Confidence Intervals
disability
nervous system

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Ecology, Evolution, Behavior and Systematics
  • Cancer Research
  • Genetics(clinical)

Cite this

Saarela, J., Kallio, S. P., Chen, D., Montpetit, A., Jokiaho, A., Choi, E., ... Peltonen, L. (2006). PRKCA and multiple sclerosis: association in two independent populations. PLoS Genetics, 2(3). https://doi.org/10.1371/journal.pgen.0020042

PRKCA and multiple sclerosis : association in two independent populations. / Saarela, Janna; Kallio, Suvi P.; Chen, Daniel; Montpetit, Alexandre; Jokiaho, Anne; Choi, Eva; Asselta, Rosanna; Bronnikov, Denis; Lincoln, Matthew R.; Sadovnick, A. Dessa; Tienari, Pentti J.; Koivisto, Keijo; Palotie, Aarno; Ebers, George C.; Hudson, Thomas J.; Peltonen, Leena.

In: PLoS Genetics, Vol. 2, No. 3, 03.2006.

Research output: Contribution to journalArticle

Saarela, J, Kallio, SP, Chen, D, Montpetit, A, Jokiaho, A, Choi, E, Asselta, R, Bronnikov, D, Lincoln, MR, Sadovnick, AD, Tienari, PJ, Koivisto, K, Palotie, A, Ebers, GC, Hudson, TJ & Peltonen, L 2006, 'PRKCA and multiple sclerosis: association in two independent populations.', PLoS Genetics, vol. 2, no. 3. https://doi.org/10.1371/journal.pgen.0020042
Saarela, Janna ; Kallio, Suvi P. ; Chen, Daniel ; Montpetit, Alexandre ; Jokiaho, Anne ; Choi, Eva ; Asselta, Rosanna ; Bronnikov, Denis ; Lincoln, Matthew R. ; Sadovnick, A. Dessa ; Tienari, Pentti J. ; Koivisto, Keijo ; Palotie, Aarno ; Ebers, George C. ; Hudson, Thomas J. ; Peltonen, Leena. / PRKCA and multiple sclerosis : association in two independent populations. In: PLoS Genetics. 2006 ; Vol. 2, No. 3.
@article{d5a02682a74a4d508dec37c220769665,
title = "PRKCA and multiple sclerosis: association in two independent populations.",
abstract = "Multiple sclerosis (MS) is a chronic disease of the central nervous system responsible for a large portion of neurological disabilities in young adults. Similar to what occurs in numerous complex diseases, both unknown environmental factors and genetic predisposition are required to generate MS. We ascertained a set of 63 Finnish MS families, originating from a high-risk region of the country, to identify a susceptibility gene within the previously established 3.4-Mb region on 17q24. Initial single nucleotide polymorphism (SNP)-based association implicated PRKCA (protein kinase C alpha) gene, and this association was replicated in an independent set of 148 Finnish MS families (p = 0.0004; remaining significant after correction for multiple testing). Further, a dense set of 211 SNPs evenly covering the PRKCA gene and the flanking regions was selected from the dbSNP database and analyzed in two large, independent MS cohorts: in 211 Finnish and 554 Canadian MS families. A multipoint SNP analysis indicated linkage to PRKCA and its telomeric flanking region in both populations, and SNP haplotype and genotype combination analyses revealed an allelic variant of PRKCA, which covers the region between introns 3 and 8, to be over-represented in Finnish MS cases (odds ratio = 1.34, 95{\%} confidence interval 1.07-1.68). A second allelic variant, covering the same region of the PRKCA gene, showed somewhat stronger evidence for association in the Canadian families (odds ratio = 1.64, 95{\%} confidence interval 1.39-1.94). Initial functional relevance for disease predisposition was suggested by the expression analysis: The transcript levels of PRKCA showed correlation with the copy number of the Finnish and Canadian {"}risk{"} haplotypes in CD4-negative mononuclear cells of five Finnish multiplex families and in lymphoblast cell lines of 11 Centre d'Etude du Polymorphisme Humain (CEPH) individuals of European origin.",
author = "Janna Saarela and Kallio, {Suvi P.} and Daniel Chen and Alexandre Montpetit and Anne Jokiaho and Eva Choi and Rosanna Asselta and Denis Bronnikov and Lincoln, {Matthew R.} and Sadovnick, {A. Dessa} and Tienari, {Pentti J.} and Keijo Koivisto and Aarno Palotie and Ebers, {George C.} and Hudson, {Thomas J.} and Leena Peltonen",
year = "2006",
month = "3",
doi = "10.1371/journal.pgen.0020042",
language = "English",
volume = "2",
journal = "PLoS Genetics",
issn = "1553-7390",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - PRKCA and multiple sclerosis

T2 - association in two independent populations.

AU - Saarela, Janna

AU - Kallio, Suvi P.

AU - Chen, Daniel

AU - Montpetit, Alexandre

AU - Jokiaho, Anne

AU - Choi, Eva

AU - Asselta, Rosanna

AU - Bronnikov, Denis

AU - Lincoln, Matthew R.

AU - Sadovnick, A. Dessa

AU - Tienari, Pentti J.

AU - Koivisto, Keijo

AU - Palotie, Aarno

AU - Ebers, George C.

AU - Hudson, Thomas J.

AU - Peltonen, Leena

PY - 2006/3

Y1 - 2006/3

N2 - Multiple sclerosis (MS) is a chronic disease of the central nervous system responsible for a large portion of neurological disabilities in young adults. Similar to what occurs in numerous complex diseases, both unknown environmental factors and genetic predisposition are required to generate MS. We ascertained a set of 63 Finnish MS families, originating from a high-risk region of the country, to identify a susceptibility gene within the previously established 3.4-Mb region on 17q24. Initial single nucleotide polymorphism (SNP)-based association implicated PRKCA (protein kinase C alpha) gene, and this association was replicated in an independent set of 148 Finnish MS families (p = 0.0004; remaining significant after correction for multiple testing). Further, a dense set of 211 SNPs evenly covering the PRKCA gene and the flanking regions was selected from the dbSNP database and analyzed in two large, independent MS cohorts: in 211 Finnish and 554 Canadian MS families. A multipoint SNP analysis indicated linkage to PRKCA and its telomeric flanking region in both populations, and SNP haplotype and genotype combination analyses revealed an allelic variant of PRKCA, which covers the region between introns 3 and 8, to be over-represented in Finnish MS cases (odds ratio = 1.34, 95% confidence interval 1.07-1.68). A second allelic variant, covering the same region of the PRKCA gene, showed somewhat stronger evidence for association in the Canadian families (odds ratio = 1.64, 95% confidence interval 1.39-1.94). Initial functional relevance for disease predisposition was suggested by the expression analysis: The transcript levels of PRKCA showed correlation with the copy number of the Finnish and Canadian "risk" haplotypes in CD4-negative mononuclear cells of five Finnish multiplex families and in lymphoblast cell lines of 11 Centre d'Etude du Polymorphisme Humain (CEPH) individuals of European origin.

AB - Multiple sclerosis (MS) is a chronic disease of the central nervous system responsible for a large portion of neurological disabilities in young adults. Similar to what occurs in numerous complex diseases, both unknown environmental factors and genetic predisposition are required to generate MS. We ascertained a set of 63 Finnish MS families, originating from a high-risk region of the country, to identify a susceptibility gene within the previously established 3.4-Mb region on 17q24. Initial single nucleotide polymorphism (SNP)-based association implicated PRKCA (protein kinase C alpha) gene, and this association was replicated in an independent set of 148 Finnish MS families (p = 0.0004; remaining significant after correction for multiple testing). Further, a dense set of 211 SNPs evenly covering the PRKCA gene and the flanking regions was selected from the dbSNP database and analyzed in two large, independent MS cohorts: in 211 Finnish and 554 Canadian MS families. A multipoint SNP analysis indicated linkage to PRKCA and its telomeric flanking region in both populations, and SNP haplotype and genotype combination analyses revealed an allelic variant of PRKCA, which covers the region between introns 3 and 8, to be over-represented in Finnish MS cases (odds ratio = 1.34, 95% confidence interval 1.07-1.68). A second allelic variant, covering the same region of the PRKCA gene, showed somewhat stronger evidence for association in the Canadian families (odds ratio = 1.64, 95% confidence interval 1.39-1.94). Initial functional relevance for disease predisposition was suggested by the expression analysis: The transcript levels of PRKCA showed correlation with the copy number of the Finnish and Canadian "risk" haplotypes in CD4-negative mononuclear cells of five Finnish multiplex families and in lymphoblast cell lines of 11 Centre d'Etude du Polymorphisme Humain (CEPH) individuals of European origin.

UR - http://www.scopus.com/inward/record.url?scp=33746702643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746702643&partnerID=8YFLogxK

U2 - 10.1371/journal.pgen.0020042

DO - 10.1371/journal.pgen.0020042

M3 - Article

C2 - 16596167

AN - SCOPUS:33645766966

VL - 2

JO - PLoS Genetics

JF - PLoS Genetics

SN - 1553-7390

IS - 3

ER -